A Research Study to See How NNC0487-0111 Affects the Body's Energy Use After a Weight Loss in Adults Living With Overweight or Obesity, Compared to a Low-calorie Diet or Placebo

Locations

Denmark, Netherlands

Start date

03/08/2026

Identifiers

Trial ID NN9490-8152,
NCT number NCT07757087,
Eudract number Not Available

Summary

The purpose of this clinical study is to evaluate how NNC0487-0111 affects the amount of energy the body uses in people living with obesity or overweight following weight loss. This will be compared with the amount of energy used by participants who achieve weight loss through a low-calorie diet and by participants receiving placebo (without weight loss).

Trial Overview:

Condition

Overweight

Obesity

Treatment

DRUG: NNC0487-0111

DRUG: Placebo

BEHAVIORAL: LED

Study type

INTERVENTIONAL

Trial duration

Aug 03 2026 - Sep 18 2028

Participants

120

Phase

Are you eligible?

Gender

Male and female

Age

18 years and older

Find out how you can participate

Questions or concerns

Do you have any question about what it’s like being a clinical volunteer? Have a look at our answers to frequently asked questions.

This site contains information about clinical trials sponsored by Novo Nordisk. It is not intended to replace the advice of a healthcare professional and should not be construed as providing advice or making a recommendation. The information on this site should not be relied on as the basis for any decision or action. Only a physician can determine whether a specific product is correct for a particular patient. If you have questions regarding any information contained on this site you should consult a physician.